-
-
-
-
-
-
-
VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response Program
-
-
-
-
-
-
-
VivoPower Receives Nasdaq Approval of Ticker “TEMB” for Planned Tembo Listing at a Targeted Valuation of $838 Million
-
-
-
-
-
-
-
MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS
-
-
-
-
-
-
-
MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS
-
-
-
-
-
-
-
Meridian Bioscience Reports Third Quarter Fiscal 2021 Results
-
-
-
-
-
-
-
Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter
-
-
-
-
-
-
-
Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission
-
1,170,130 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

